As previously discussed, BRCA1 negatively regulates IGF-I, and its defectiveness keeps always active the IGF-I/PI3K-Akt pathway, which significantly promotes tumor cell survival and proliferation (45–47). This evidence concerns the gene IGF1 and neoplasm.